Annual Operating Expenses
$179.28 M
+$9.72 M+5.74%
December 31, 2023
Summary
- As of February 7, 2025, XERS annual total operating expenses is $179.28 million, with the most recent change of +$9.72 million (+5.74%) on December 31, 2023.
- During the last 3 years, XERS annual operating expenses has risen by +$84.63 million (+89.41%).
- XERS annual operating expenses is now at all-time high.
Performance
XERS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$53.57 M
+$5.11 M+10.54%
September 30, 2024
Summary
- As of February 7, 2025, XERS quarterly total operating expenses is $53.57 million, with the most recent change of +$5.11 million (+10.54%) on September 30, 2024.
- Over the past year, XERS quarterly operating expenses has increased by +$8.54 million (+18.96%).
- XERS quarterly operating expenses is now -17.35% below its all-time high of $64.81 million, reached on December 31, 2021.
Performance
XERS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
XERS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.7% | +19.0% |
| 3 y3 years | +89.4% | +19.0% |
| 5 y5 years | +190.3% | +19.0% |
XERS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.4% | -17.4% | +35.9% |
| 5 y | 5-year | at high | +89.4% | -17.4% | +163.7% |
| alltime | all time | at high | +1153.9% | -17.4% | +970.7% |
Xeris Biopharma Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $53.57 M(+10.5%) |
| Jun 2024 | - | $48.46 M(-0.9%) |
| Mar 2024 | - | $48.91 M(+4.8%) |
| Dec 2023 | $179.28 M(+5.7%) | $46.66 M(+3.6%) |
| Sep 2023 | - | $45.03 M(-3.0%) |
| Jun 2023 | - | $46.43 M(+12.8%) |
| Mar 2023 | - | $41.15 M(-2.1%) |
| Dec 2022 | $169.55 M(+12.0%) | $42.02 M(-2.8%) |
| Sep 2022 | - | $43.24 M(+9.7%) |
| Jun 2022 | - | $39.41 M(-12.2%) |
| Mar 2022 | - | $44.87 M(-30.8%) |
| Dec 2021 | $151.43 M(+60.0%) | $64.81 M(+101.3%) |
| Sep 2021 | - | $32.20 M(+2.8%) |
| Jun 2021 | - | $31.31 M(+35.5%) |
| Mar 2021 | - | $23.11 M(-0.8%) |
| Dec 2020 | $94.65 M | $23.30 M(+14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $20.32 M(-11.4%) |
| Jun 2020 | - | $22.93 M(-18.5%) |
| Mar 2020 | - | $28.14 M(-14.9%) |
| Dec 2019 | $123.50 M(+99.9%) | $33.06 M(+8.8%) |
| Sep 2019 | - | $30.39 M(-11.5%) |
| Jun 2019 | - | $34.36 M(+33.8%) |
| Mar 2019 | - | $25.68 M(+21.6%) |
| Dec 2018 | $61.77 M(+119.2%) | $21.11 M(+36.0%) |
| Sep 2018 | - | $15.53 M(+17.8%) |
| Jun 2018 | - | $13.18 M(+10.3%) |
| Mar 2018 | - | $11.95 M(+23.5%) |
| Dec 2017 | $28.18 M(+97.1%) | $9.68 M(+25.0%) |
| Sep 2017 | - | $7.74 M(+34.4%) |
| Jun 2017 | - | $5.76 M(+15.1%) |
| Mar 2017 | - | $5.00 M |
| Dec 2016 | $14.30 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual operating expenses year-on-year change?
- What is Xeris Biopharma Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly operating expenses year-on-year change?
What is Xeris Biopharma Holdings annual total operating expenses?
The current annual operating expenses of XERS is $179.28 M
What is the all time high annual operating expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total operating expenses is $179.28 M
What is Xeris Biopharma Holdings annual operating expenses year-on-year change?
Over the past year, XERS annual total operating expenses has changed by +$9.72 M (+5.74%)
What is Xeris Biopharma Holdings quarterly total operating expenses?
The current quarterly operating expenses of XERS is $53.57 M
What is the all time high quarterly operating expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total operating expenses is $64.81 M
What is Xeris Biopharma Holdings quarterly operating expenses year-on-year change?
Over the past year, XERS quarterly total operating expenses has changed by +$8.54 M (+18.96%)